Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Colleen Kusy is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/15/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | OCS | Buy Now | Oculis Holding | $13.00 | 215.38% | Colleen Kusy33% | $37 → $41 | Maintains | Outperform | Get Alert |
| 03/12/2025 | AGEN | Buy Now | Agenus | $1.86 | 61.29% | Colleen Kusy33% | $6 → $3 | Maintains | Neutral | Get Alert |
| 12/05/2024 | CHRS | Buy Now | Coherus BioSciences | $0.96 | 525% | Colleen Kusy33% | $4 → $6 | Maintains | Outperform | Get Alert |
| 11/15/2024 | ELVN | Buy Now | Enliven Therapeutics | $17.19 | 132.69% | Colleen Kusy33% | $32 → $40 | Maintains | Outperform | Get Alert |
| 11/13/2024 | SYRE | Buy Now | Spyre Therapeutics | $12.80 | 407.81% | Colleen Kusy33% | $50 → $65 | Maintains | Outperform | Get Alert |
| 11/08/2024 | CHRS | Buy Now | Coherus BioSciences | $0.96 | 316.67% | Colleen Kusy33% | $8 → $4 | Maintains | Outperform | Get Alert |
| 11/07/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 184.53% | Colleen Kusy33% | $92 → $55 | Maintains | Outperform | Get Alert |
| 09/23/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 375.94% | Colleen Kusy33% | $96 → $92 | Maintains | Outperform | Get Alert |
| 08/14/2024 | MRSN | Buy Now | Mersana Therapeutics | $0.33 | 808.54% | Colleen Kusy33% | $4 → $3 | Maintains | Neutral | Get Alert |
| 08/09/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 396.64% | Colleen Kusy33% | $86 → $96 | Maintains | Outperform | Get Alert |
| 08/08/2024 | OCUL | Buy Now | Ocular Therapeutix | $7.30 | 132.88% | Colleen Kusy33% | $18 → $17 | Maintains | Outperform | Get Alert |
| 07/26/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 344.9% | Colleen Kusy33% | $100 → $86 | Maintains | Outperform | Get Alert |
| 07/23/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 417.33% | Colleen Kusy33% | $100 → $100 | Maintains | Outperform | Get Alert |
| 07/01/2024 | CHRS | Buy Now | Coherus BioSciences | $0.96 | 733.33% | Colleen Kusy33% | $9 → $8 | Maintains | Outperform | Get Alert |
| 06/28/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 417.33% | Colleen Kusy33% | $100 → $100 | Maintains | Outperform | Get Alert |
| 06/11/2024 | OCS | Buy Now | Oculis Holding | $13.00 | 184.62% | Colleen Kusy33% | $35 → $37 | Maintains | Outperform | Get Alert |
| 06/11/2024 | ELVN | Buy Now | Enliven Therapeutics | $17.19 | 86.15% | Colleen Kusy33% | → $32 | Initiates | → Outperform | Get Alert |
| 05/02/2024 | SYRE | Buy Now | Spyre Therapeutics | $12.80 | 290.63% | Colleen Kusy33% | → $50 | Initiates | → Outperform | Get Alert |
| 03/19/2024 | OCS | Buy Now | Oculis Holding | $13.00 | 169.23% | Colleen Kusy33% | $64 → $35 | Maintains | Outperform | Get Alert |
| 03/12/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $5.11 | 389.24% | Colleen Kusy33% | $27 → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 02/29/2024 | MRSN | Buy Now | Mersana Therapeutics | $0.33 | 1414.23% | Colleen Kusy33% | $1 → $5 | Maintains | Neutral | Get Alert |
| 02/23/2024 | NUVL | Buy Now | Nuvalent | $69.44 | 51.21% | Colleen Kusy33% | → $105 | Initiates | → Outperform | Get Alert |
| 02/06/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 319.04% | Colleen Kusy33% | → $81 | Reiterates | Outperform → Outperform | Get Alert |
| 01/23/2024 | CHRS | Buy Now | Coherus BioSciences | $0.96 | 837.5% | Colleen Kusy33% | $11 → $9 | Maintains | Outperform | Get Alert |
| 01/17/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 319.04% | Colleen Kusy33% | $71 → $81 | Maintains | Outperform | Get Alert |
| 11/17/2023 | CHRS | Buy Now | Coherus BioSciences | $0.96 | 1045.83% | Colleen Kusy33% | → $11 | Initiates | → Outperform | Get Alert |
| 09/14/2023 | OCUL | Buy Now | Ocular Therapeutix | $7.30 | 146.58% | Colleen Kusy33% | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 262.13% | Colleen Kusy33% | $115 → $70 | Maintains | Outperform | Get Alert |
| 07/28/2023 | MRSN | Buy Now | Mersana Therapeutics | $0.33 | 202.85% | Colleen Kusy33% | $7 → $1 | Downgrade | Outperform → Neutral | Get Alert |
| 06/20/2023 | SURF | Buy Now | Surface Oncology | — | — | Colleen Kusy33% | — | Downgrade | Outperform → Neutral | Get Alert |
| 06/13/2023 | OCUL | Buy Now | Ocular Therapeutix | $7.30 | 64.38% | Colleen Kusy33% | $10 → $12 | Maintains | Outperform | Get Alert |
| 06/08/2023 | OCS | Buy Now | Oculis Holding | $13.00 | 346.15% | Colleen Kusy33% | → $58 | Initiates | → Outperform | Get Alert |
| 06/06/2023 | AGEN | Buy Now | Agenus | $1.86 | 330.11% | Colleen Kusy33% | → $160 | Initiates | → Outperform | Get Alert |
| 05/04/2023 | SURF | Buy Now | Surface Oncology | — | — | Colleen Kusy33% | → $6 | Maintains | Outperform | Get Alert |
| 05/04/2023 | ISEE | Buy Now | IVERIC bio | — | — | Colleen Kusy33% | → $40 | Downgrade | Outperform → Neutral | Get Alert |
| 04/21/2023 | OCUL | Buy Now | Ocular Therapeutix | $7.30 | 146.58% | Colleen Kusy33% | → $18 | Initiates | → Outperform | Get Alert |
| 02/21/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $19.33 | 443.2% | Colleen Kusy33% | $90 → $105 | Maintains | Outperform | Get Alert |
| 11/15/2022 | HARP | Buy Now | Harpoon Therapeutics | — | — | Colleen Kusy33% | — | Downgrade | Outperform → Neutral | Get Alert |
| 11/03/2022 | SURF | Buy Now | Surface Oncology | — | — | Colleen Kusy33% | $11 → $6 | Maintains | Outperform | Get Alert |
| 10/19/2022 | AVEO | Buy Now | AVEO Pharmaceuticals | — | — | Colleen Kusy33% | $17 → $15 | Downgrade | Outperform → Neutral | Get Alert |
| 09/07/2022 | ISEE | Buy Now | IVERIC bio | — | — | Colleen Kusy33% | $27 → $34 | Maintains | Outperform | Get Alert |
| 08/09/2022 | MRSN | Buy Now | Mersana Therapeutics | $0.33 | 5956.94% | Colleen Kusy33% | $18 → $20 | Maintains | Outperform | Get Alert |
| 08/05/2022 | KPTI | Buy Now | Karyopharm Therapeutics | $4.08 | 243.14% | Colleen Kusy33% | $255 → $210 | Maintains | Outperform | Get Alert |
| 08/03/2022 | SURF | Buy Now | Surface Oncology | — | — | Colleen Kusy33% | $11 → $11 | Maintains | Outperform | Get Alert |
| 05/09/2022 | SURF | Buy Now | Surface Oncology | — | — | Colleen Kusy33% | $11 → $11 | Maintains | Outperform | Get Alert |
| 04/13/2022 | SURF | Buy Now | Surface Oncology | — | — | Colleen Kusy33% | → $11 | Maintains | Outperform | Get Alert |
| 04/07/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.33 | 921.02% | Colleen Kusy33% | $30 → $34 | Maintains | Outperform | Get Alert |
| 03/03/2022 | ISEE | Buy Now | IVERIC bio | — | — | Colleen Kusy33% | → $27 | Initiates | → Outperform | Get Alert |
| 02/25/2022 | IOVA | Buy Now | Iovance Biotherapeutics | $3.33 | 800.9% | Colleen Kusy33% | $35 → $30 | Maintains | Outperform | Get Alert |
| 11/02/2021 | SABS | Buy Now | SAB Biotherapeutics | $1.40 | 1542.86% | Colleen Kusy33% | → $230 | Initiates | → Outperform | Get Alert |
| 05/06/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $3.33 | 1851.95% | Colleen Kusy33% | $60 → $65 | Maintains | Outperform | Get Alert |
| 11/05/2019 | IOVA | Buy Now | Iovance Biotherapeutics | $3.33 | 1701.8% | Colleen Kusy33% | $56 → $60 | Maintains | Outperform | Get Alert |
| 02/07/2019 | IOVA | Buy Now | Iovance Biotherapeutics | $3.33 | 770.87% | Colleen Kusy33% | → $29 | Initiates | → Outperform | Get Alert |
